Biotech RadarJobs updated

COMPANY

Epitel

HQ: Salt Lake City, UT source · epitel.com ↗ · Mountain

FDA-cleared device company

Location: Salt Lake City, UT · source · Oct 14, 2026

Profile checked Oct 10, 2026

Keywords: Epilepsy Seizures Epitel's™ Remote EEG Monitoring System's (REMI™)

3Trials (company is sponsor)2FDA records (2 yrs)21NIH grants

Timeline

  1. FDA FDA 510(k) clearance: REMI Remote EEG Monitoring System — K243185, Mar 21, 2025. Applicant at approval: Epitel. source ↗
  2. FDA FDA 510(k) clearance: REMI-AI Rapid Detection Module (REMI-AI RDM) — K240408, Oct 17, 2024. Applicant at approval: Epitel, Inc. source ↗
  3. Trial start Not phased (device or behavioral study): Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System. source ↗
  4. Trial start Not phased (device or behavioral study): Assessment of Remote EEG Monitoring (REMI-EEG) in Pediatric Emergency and Adult Critical Care Units source ↗
  5. Trial start Not phased (device or behavioral study): A Wireless EEG Patch for Continuous Electrographic Monitoring source ↗

Clinical trials (lead sponsor) 3

RecordTitlePhaseStatusStartPrimary completion
NCT06027749Impact of Capturing Ictal Events With Ultra-long-term Ambulatory EEG Monitoring With Remote EEG Monitoring System.Not phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Oct 13, 2023Mar 30, 2025 (estimated)
NCT03583957A Wireless EEG Patch for Continuous Electrographic MonitoringNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)May 8, 2018Apr 30, 2026 (estimated)
NCT05818930Assessment of Remote EEG Monitoring (REMI-EEG) in Pediatric Emergency and Adult Critical Care UnitsNot phased (device or behavioral study)Unknown status (ClinicalTrials.gov)Mar 8, 20232025-06 (estimated)

FDA records (last 2 years)

NIH awards 21

Annual award amounts. Total $17.1M.

Feedback